Catalog Number 606-004-100 |
Device Problem
Device Operates Differently Than Expected (2913)
|
Patient Problems
Seroma (2069); Injury (2348); Tissue Breakdown (2681)
|
Event Type
Injury
|
Manufacturer Narrative
|
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based on the reported information.
|
|
Event Description
|
It was reported that the patient presented 2 weeks postoperatively with a mild wound breakdown medially to lateral incision, lateral to the areola.A 2-3mm opening resulting in excessive amounts of clear yellow fluid ¿seroma¿.On exploration surgimend was found to be ¿stretching¿ or degrading at the fenestrations sub-dermal to the site of wound breakdown.Nothing grown in culture.Treated with antibiotics and cleaned out using betadine.
|
|
Manufacturer Narrative
|
Integra has completed their internal investigation on february 15, 2018.Results: unable to conduct failure analysis and root cause due to product not being returned (implanted in patient) dhr review; no abnormalities were found and all manufacturing related process steps were followed and documented per listed instructions and current good manufacturing practices.Complaints history; a query of the trackwise complaints database for the timeframe of 10jan2017 ¿ 10jan2018 was performed using the keywords: ¿surgimend,¿ ¿degraded, ¿ and ¿degrading¿ this is the only complaint related to ¿surgimend ¿ degrading".(b)(4).
|
|
Manufacturer Narrative
|
The failure is unconfirmed and failure analysis could not be performed as the product has not been returned (still implanted in the patient).If product is returned at a later date, the complaint investigation will be updated as applicable.Root cause is indeterminable.The device was not returned for failure analysis as it remains implanted in the patient (per complaint documentation).There were no anomalies found in the dhr review.Based on the dhr review conducted, there is no indication that the manufacturing processes may have contributed to this complaint.Additionally, all finished goods lots released to the market by integra lifesciences meet raw material, in-process and finished goods release acceptance criteria for all required inspections and tests.
|
|
Search Alerts/Recalls
|